Results 111 to 120 of about 4,685 (255)

Safety of Remimazolam in Vulnerable Populations

open access: yesDrug Design, Development and Therapy
Vulnerable populations require careful consideration in drug selection due to their unique physiological conditions. Remimazolam, an innovative ultra-short-acting benzodiazepine, presents several advantages, including rapid onset, brief duration of action, and high predictability.
Jia-Yi Ge   +3 more
openaire   +4 more sources

脊髄後角ニューロンの抑制性伝達に対するレミマゾラムの作用 [PDF]

open access: yes
新潟大学Niigata University博士(医学)Remimazolam is an ultra-short benzodiazepine that acts on the benzodiazepine site of γ-aminobutyric acid (GABA) receptors in the brain and induces sedation. Although GABA receptors are found localized in the spinal dorsal horn,
Hoshino, Rintaro, 星野, 林太郎
core   +1 more source

Remimazolam Besylate

open access: yesAmerican Journal of Health-System Pharmacy, 2021
openaire   +2 more sources

Remimazolam use for awake craniotomy [PDF]

open access: yesJA Clinical Reports, 2021
Shunsuke Tachibana   +2 more
openaire   +3 more sources

Clinical Pharmacokinetics and Pharmacodynamics of Remimazolam

open access: yesClinical Pharmacokinetics
Remimazolam is a benzodiazepine with a high affinity for the γ-aminobutyric acid type A-receptor thereby inducing sedation and amnesia. It is a short-acting drug, has a fast onset, short duration of action, and a predictable recovery profile. Remimazolam is metabolized mainly into CNS7054.
Bas T. de Jong   +3 more
openaire   +2 more sources

Comparison of efficacy and safety of equivalent doses of remimazolam versus propofol for gastroscopy anesthesia in elderly patients

open access: yesScientific Reports
Remimazolam, a novel intravenous anesthetic, has been proven to be safe and efficacious in the gastroscopy setting among the elderly. However, reports comparing the effectiveness and safety of using equivalent doses of remimazolam with propofol have not ...
Di Chen   +4 more
doaj   +1 more source

Anesthetic management with remimazolam for a patient with hereditary angioedema : a case report [PDF]

open access: yes
Background : Hereditary angioedema (HAE), a genetic disorder caused by C1-inhibitor deficiency or dysfunction, may cause mucosal edema in the upper airway during tracheal intubation and extubation.
343   +24 more
core  

Remimazolam-etomidate versus remimazolam-propofol for gastrointestinal endoscopy: A randomized controlled trial

open access: yesPLOS One
Objective The optimal sedation strategy for gastrointestinal endoscopy remains debated. This study compared the efficacy and safety of remimazolam combined with etomidate versus propofol for procedural sedation during gastrointestinal endoscopy. Methods This single-center, randomized controlled clinical trial was performed from March 2024 to April ...
Baoyu Ma   +3 more
openaire   +4 more sources

Long-term sedation with remimazolam besylate versus propofol in critically ill patients during invasive mechanical ventilation: a study protocol for a multicenter randomized non-inferior trial [PDF]

open access: gold, 2023
Xiaobo Yang   +10 more
openalex   +1 more source

Home - About - Disclaimer - Privacy